Clinical and biochemical improvement with galactose supplementation in SLC35A2-CDG.

Address: Department of Paediatrics and Metabolic Center, University Hospitals Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.; Department of Clinical Genomics, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.; Department of Clinical Genetics, United Laboratories, Tartu University Hospital, Tartu, Estonia.; Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.; Children's & Women's Health Centre of British Columbia, Vancouver, BC, Canada.; Center for Inherited Metabolic Diseases, Department of Pediatrics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.; Department of Pediatrics, University of Illinois, IL, Chicago, USA.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.; Texas Children's Hospital, Houston, TX, USA.; Joint BCM-CUHK Center of Medical Genetics, Prince of Wales Hospital, Shatin, Hong Kong.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.; Genetic and Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.; Department of Inborn Errors of Metabolism and Paediatrics, Institute of Mother and Child, Warsaw, Poland.; Department of Pediatrics, Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Paediatrics and Metabolic Center, University Hospitals Leuven, Leuven, Belgium. [email protected].; Department of Development and Regeneration, KU Leuven, Leuven, Belgium. [email protected].; Department of Clinical Genomics, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA. [email protected].